Fig. 1From: Bedaquiline safety, efficacy, utilization and emergence of resistance following treatment of multidrug-resistant tuberculosis patients in South Africa: a retrospective cohort analysisKaplan–Meier survival curve for deaths defined per WHO treatment outcome for A MDR-TB-infected patients, B pre-XDR-TB-infected patients and C XDR-TB-infected patients in South Africa treated with bedaquiline- or non-bedaquiline-containing regimensBack to article page